|
🐜
|
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
28 auth.
P. Harter,
J. Sehouli,
D. Lorusso,
A. Reuss,
I. Vergote,
C. Marth,
Jae-Weon Kim,
F. Raspagliesi,
B. Lampe,
G. Aletti,
W. Meier,
D. Cibula,
A. Mustea,
S. Mahner,
I. Runnebaum,
...
B. Schmalfeldt,
A. Burges,
R. Kimmig,
G. Scambia,
S. Greggi,
F. Hilpert,
A. Hasenburg,
P. Hillemanns,
G. Giorda,
Ingo von Leffern,
C. Schade-Brittinger,
U. Wagner,
A. du Bois
|
8 |
2019 |
8
🐜
|
|
🐜
|
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
10 auth.
Steffen Runz,
Sascha Keller,
C. Rupp,
Alexander Stoeck,
Yasmin Issa,
D. Koensgen,
...
A. Mustea,
J. Sehouli,
G. Kristiansen,
P. Altevogt
|
8 |
2007 |
8
🐜
|
|
🐜
|
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.
20 auth.
Georg Wieczorek,
A. Asemissen,
F. Model,
Ivana Turbachova,
S. Floess,
Volker Liebenberg,
U. Baron,
D. Stauch,
K. Kotsch,
J. Pratschke,
...
A. Hamann,
C. Loddenkemper,
H. Stein,
H. Volk,
U. Hoffmüller,
A. Grützkau,
A. Mustea,
J. Huehn,
C. Scheibenbogen,
S. Olek
|
8 |
2009 |
8
🐜
|
|
🐜
|
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
9 auth.
Sascha Keller,
A. König,
F. Marmé,
Steffen Runz,
S. Wolterink,
D. Koensgen,
...
A. Mustea,
J. Sehouli,
P. Altevogt
|
8 |
2009 |
8
🐜
|
|
🐜
|
The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications
8 auth.
I. Meinhold-Heerlein,
C. Fotopoulou,
P. Harter,
C. Kurzeder,
A. Mustea,
P. Wimberger,
...
S. Hauptmann,
J. Sehouli
|
7 |
2016 |
7
🐜
|
|
🐜
|
Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer
12 auth.
L. Hefler,
N. Concin,
G. Hofstetter,
C. Marth,
A. Mustea,
J. Sehouli,
...
R. Zeillinger,
H. Leipold,
H. Lass,
C. Grimm,
C. Tempfer,
A. Reinthaller
|
7 |
2008 |
7
🐜
|
|
🐜
|
Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study
19 auth.
S. Mahner,
J. Jueckstock,
F. Hilpert,
P. Neuser,
P. Harter,
N. de Gregorio,
A. Hasenburg,
J. Sehouli,
Annika Habermann,
P. Hillemanns,
...
S. Fuerst,
H. Strauß,
K. Baumann,
F. Thiel,
A. Mustea,
W. Meier,
A. du Bois,
L. Griebel,
L. Woelber
|
7 |
2015 |
7
🐜
|
|
🐜
|
Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.
11 auth.
J. Sehouli,
Frank S. Drescher,
A. Mustea,
D. Elling,
W. Friedmann,
W. Kühn,
...
M. Nehmzow,
F. Opri,
P. Klare,
M. Dietel,
W. Lichtenegger
|
6 |
2004 |
6
🐜
|
|
🐜
|
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum‐induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
10 auth.
L. Nicholson,
PaulR . Smith,
L. Hiller,
P. Szlosarek,
C. Kimberley,
J. Sehouli,
...
D. Koensgen,
A. Mustea,
P. Schmid,
T. Crook
|
6 |
2009 |
6
🐜
|
|
🐜
|
Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells
8 auth.
P. Sun,
J. Sehouli,
C. Denkert,
A. Mustea,
D. Könsgen,
Ines Koch,
...
Lihui Wei,
W. Lichtenegger
|
6 |
2005 |
6
🐜
|
|
🐜
|
Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer
12 auth.
L. Hefler,
A. Mustea,
D. Könsgen,
N. Concin,
B. Tanner,
R. Strick,
...
G. Heinze,
C. Grimm,
Eva Schuster,
C. Tempfer,
A. Reinthaller,
R. Zeillinger
|
6 |
2007 |
6
🐜
|
